Humacyte, Inc. · NASDAQ:HUMA
Humacyte, Inc. shareholders
As of Jun 30, 2026, 159 institutions reported holding Humacyte, Inc., 26.4% of its shares. Largest: Vanguard, ANTIPODES PARTNERS Ltd and Alyeska Investment Group, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Humacyte, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 11.9M | 4.3% | +2.27M | Aug 13, 2026 |
| ANTIPODES PARTNERS Ltd | 10.1M | 3.6% | +4.38M | Aug 6, 2026 |
| Alyeska Investment Group, L.P. | 6.02M | 2.2% | new | Aug 14, 2026 |
| Davidson Kempner Capital Management LP | 5M | 1.8% | new | Aug 14, 2026 |
| BlackRock | 4.84M | 1.7% | −7.48M | Aug 7, 2026 |
| Great Point Partners LLC | 3.75M | 1.3% | no change | Aug 14, 2026 |
| UBS | 2.84M | 1.0% | +61,423 | Aug 13, 2026 |
| AQR Capital Management LLC | 2.6M | 0.93% | +672K | Aug 14, 2026 |
| Geode Capital | 2.19M | 0.79% | −1.47M | Aug 12, 2026 |
| Millennium | 1.91M | 0.69% | +1.8M | Aug 14, 2026 |